Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Rhabdoid Tumor × Dexamethasone × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 220 Precursor Cell Lymphoblastic Leukemia-Lymphoma 46 Recurrence 31 Neoplasms 20 Burkitt Lymphoma 20 Neoplasms, Plasma Cell 16 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12 Immunoglobulin Light-chain Amyloidosis 11 Neoplasm Metastasis 10 Leukemia 10 Lung Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Breast Neoplasms 8 Prostatic Neoplasms 7 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, Myeloid, Acute 7 Lymphoma 6 Leukemia, Biphenotypic, Acute 6 Lymphoma, Non-Hodgkin 5 Triple Negative Breast Neoplasms 4 Smoldering Multiple Myeloma 4 Neoplasm, Residual 4 Lymphoma, Mantle-Cell 4 Hodgkin Disease 4 Colorectal Neoplasms 4 Brain Neoplasms 4 Waldenstrom Macroglobulinemia 3 Vomiting 3 Rectal Neoplasms 3 Plasmacytoma 3

Interventions

Magnetic Resonance Spectroscopy 7 X-Rays 6 Phantoms, Imaging 6 Cyclophosphamide 6 fludarabine 5 Specimen Handling 5 Nuclear Medicine Department, Hospital 5 Biopsy 4 etoposide phosphate 3 Etoposide 3 Automobiles 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 fludarabine phosphate 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Sirolimus 2 Nivolumab 2 Methotrexate 2 Ipilimumab 2 talazoparib 1 selinexor 1 pembrolizumab 1 palbociclib 1 omburtamab I-131 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡